Atovaquone Suspension
Product Images NDC 72603-248

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 72603-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

Chemical structure of Atovaquone, showing its molecular framework including a naphthoquinone moiety and a chlorophenyl group attached to a cyclohexane ring.*

FDA Label Image

Atovaquoneoscarton (Atovaquoneoscarton)

Box packaging for Atovaquone Oral Suspension, USP 750 mg/5 mL, an oral suspension in a 210 mL container. The label includes dosage strength, usage directions to see accompanying prescribing information, storage instructions at 15-25°C, and the manufacturer, NorthStar Rx LLC, Memphis, TN, with manufacturing by Hetero Labs Limited, India. A barcode and lot details are also present.*

FDA Label Image

Atovaquoneoscontainer (Atovaquoneoscontainer)

Label for Atovaquone Oral Suspension USP, containing 750 mg per 5 mL, in a 210 mL bottle. The label indicates it is for prescription use only, manufactured for NorthStar Rx LLC, and includes storage instructions and a barcode. The label also notes it should be shaken gently before use and not frozen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.